MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

Neptune Technologies & Bioressources Company Profile (TSE:NTB)

Consensus Ratings for Neptune Technologies & Bioressources (TSE:NTB) (?)
Ratings Breakdown: No ratings tracked in the last 12 months.
Consensus Rating:N/A (Score: NaN)
Consensus Price Target: N/A

Analysts' Ratings History for Neptune Technologies & Bioressources (TSE:NTB)
Show:
No equities research coverage for this company has been tracked by MarketBeat.com

Earnings History for Neptune Technologies & Bioressources (TSE:NTB)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallActions
7/11/2016        
7/16/2014($0.08)($0.06)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/22/2014($0.08)($0.08)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
(Data available from 1/1/2011 forward)
Earnings Estimates for Neptune Technologies & Bioressources (TSE:NTB)
No earnings estimates for this company have been tracked by MarketBeat.com

Dividend History for Neptune Technologies & Bioressources (TSE:NTB)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trading History for Neptune Technologies & Bioressources (TSE:NTB)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionActions
2/1/2016James Stuart HamiltonDirectorBuy4,000C$1.58C$6,320.00Tweet This Trade  Share This Trade on StockTwits
1/28/2016James Stuart HamiltonDirectorBuy2,000C$1.55C$3,100.00Tweet This Trade  Share This Trade on StockTwits
1/18/2016Mario ParadisInsiderBuy10,000C$1.50C$15,000.00Tweet This Trade  Share This Trade on StockTwits
1/15/2016John Morris MoretzDirectorBuy700,651C$1.05C$735,683.55Tweet This Trade  Share This Trade on StockTwits
1/15/2016Mario ParadisInsiderBuy40,000C$1.54C$61,672.00Tweet This Trade  Share This Trade on StockTwits
10/29/2015John Morris MoretzDirectorBuy26,044C$1.08C$28,101.48Tweet This Trade  Share This Trade on StockTwits
10/28/2015John Morris MoretzDirectorBuy24,500C$1.12C$27,538.00Tweet This Trade  Share This Trade on StockTwits
10/27/2015John Morris MoretzDirectorBuy5,500C$1.09C$6,006.00Tweet This Trade  Share This Trade on StockTwits
10/23/2015John Morris MoretzDirectorBuy50,000C$1.17C$58,385.00Tweet This Trade  Share This Trade on StockTwits
10/5/2015John Morris MoretzDirectorBuy13,692C$1.24C$16,991.77Tweet This Trade  Share This Trade on StockTwits
10/2/2015John Morris MoretzDirectorBuy33,900C$1.23C$41,663.10Tweet This Trade  Share This Trade on StockTwits
9/15/2015John Morris MoretzDirectorBuy9,001C$1.24C$11,161.24Tweet This Trade  Share This Trade on StockTwits
7/22/2015John Morris MoretzDirectorBuy2,800C$1.34C$3,750.60Tweet This Trade  Share This Trade on StockTwits
7/21/2015John Morris MoretzDirectorBuy21,654C$1.34C$28,975.22Tweet This Trade  Share This Trade on StockTwits
7/16/2015Pierre LemieuxDirectorSell6,250C$1.62C$10,135.00Tweet This Trade  Share This Trade on StockTwits
6/8/2015Pierre FitzgibbonDirectorBuy47,500C$1.70C$80,693.00Tweet This Trade  Share This Trade on StockTwits
2/17/2015Reed TucksonDirectorBuy10,800C$1.85C$19,931.40Tweet This Trade  Share This Trade on StockTwits
2/13/2015Michel TimperioInsiderSell10,000C$2.19C$21,870.00Tweet This Trade  Share This Trade on StockTwits
2/6/2015AndrĂ© GodinInsiderSell5,000C$2.14C$10,700.00Tweet This Trade  Share This Trade on StockTwits
2/5/2015Michel TimperioInsiderSell15,000C$2.11C$31,680.00Tweet This Trade  Share This Trade on StockTwits
1/30/2015Bel Dominique LeInsiderSell15,000C$2.30C$34,500.00Tweet This Trade  Share This Trade on StockTwits
1/29/2015Bel Dominique LeInsiderSell10,000C$2.25C$22,500.00Tweet This Trade  Share This Trade on StockTwits
1/22/2015Claudie LauzonInsiderSell8,334C$2.04C$16,966.36Tweet This Trade  Share This Trade on StockTwits
1/22/2015Pierre LemieuxDirectorSell11,250C$2.00C$22,500.00Tweet This Trade  Share This Trade on StockTwits
(Data available from 1/1/2013 forward)
Headlines for Neptune Technologies & Bioressources (TSE:NTB)
No headlines for this company have been tracked by MarketBeat.com

About Neptune Technologies & Bioressources

Neptune Technologies & Bioressources Inc is a Canada-based biotechnology company. The Company is engaged primarily in the development, manufacture and commercialization of marine-derived omega-3 polyunsaturated fatty acids (PUFAs). The Company has three operating segments: Neptune, Acasti Pharma Inc. and NeuroBioPharm Inc. The Company's Neptune segment produces and commercializes nutraceutical products. The Company's Acasti Pharma Inc. segment develops and commercializes medical food and pharmaceutical products for cardiovascular diseases. The Company's NeuroBioPharm Inc. segment develops medical food and pharmaceutical products for neurological diseases. The Company's lead product, Neptune Krill Oil (NKO), come in capsule form and serve as a dietary supplement to consumers. The Company's other nutraceutical products include Ecokrill Oil (EKO), Rimfrost Oil, Neptune Krill Aquatein ( NKA) and New Formulation Derived from NKO, which include NKO Beat, NKO Flex and NKO Focus.

Industry, Sector and Symbol:
  • Sector: N/A
  • Industry: N/A
  • Sub-Industry: N/A
  • Exchange: TSE
  • Symbol: NTB
  • CUSIP:
Key Metrics:
  • Previous Close: $1.31
  • 50 Day Moving Average: $1.43
  • 200 Day Moving Average: $1.43
  • P/E Ratio: N/A
  • P/E Growth: 0.00
  • Market Cap: $102.11M
  • Current Quarter EPS Consensus Estimate: $0.04 EPS
Additional Links:
Neptune Technologies & Bioressources (TSE:NTB) Chart for Friday, June, 24, 2016


            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by StockTwits As Featured by Seeking Alpha